Tideglusib
Tideglusib is a small molecule drug that has been investigated for its potential therapeutic effects in various medical conditions, including Alzheimer's disease and autism spectrum disorder. It functions primarily as an inhibitor of glycogen synthase kinase 3 (GSK-3), an enzyme involved in numerous cellular processes.
Mechanism of Action[edit | edit source]
Tideglusib inhibits the activity of glycogen synthase kinase 3 (GSK-3), which plays a crucial role in the regulation of various cellular functions, including glycogen metabolism, cell proliferation, and apoptosis. By inhibiting GSK-3, Tideglusib can modulate these processes, potentially leading to therapeutic benefits in diseases characterized by dysregulated GSK-3 activity.
Therapeutic Applications[edit | edit source]
Alzheimer's Disease[edit | edit source]
Tideglusib has been studied for its potential to treat Alzheimer's disease, a neurodegenerative disorder characterized by the accumulation of beta-amyloid plaques and neurofibrillary tangles in the brain. By inhibiting GSK-3, Tideglusib may reduce the formation of these pathological features and improve cognitive function.
Autism Spectrum Disorder[edit | edit source]
Research has also explored the use of Tideglusib in treating autism spectrum disorder (ASD). GSK-3 is involved in the regulation of synaptic plasticity and neurodevelopment, processes that are often disrupted in ASD. Tideglusib's inhibition of GSK-3 may help to normalize these processes and alleviate some symptoms of ASD.
Other Potential Uses[edit | edit source]
Tideglusib has been investigated for its potential in treating other conditions, such as progressive supranuclear palsy and myotonic dystrophy. Its broad mechanism of action suggests that it may have therapeutic effects in a variety of diseases involving dysregulated GSK-3 activity.
Clinical Trials[edit | edit source]
Several clinical trials have been conducted to evaluate the safety and efficacy of Tideglusib in different patient populations. While some studies have shown promising results, others have not demonstrated significant benefits, highlighting the need for further research to fully understand its therapeutic potential.
Side Effects[edit | edit source]
Common side effects of Tideglusib include nausea, fatigue, and headache. More serious adverse effects are rare but may include liver toxicity and cardiac arrhythmias. Patients undergoing treatment with Tideglusib should be monitored for these potential side effects.
Related Pages[edit | edit source]
- Alzheimer's disease
- Autism spectrum disorder
- Glycogen synthase kinase 3
- Neurodegenerative disease
- Synaptic plasticity
References[edit | edit source]
External Links[edit | edit source]
-
Drug Information | |||
---|---|---|---|
Image | |||
Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD